Evidence map›Paper›PMID 41820324›Full record

ArticleCell death discovery2026

CSF1R T567M mutation induces microglial dysfunction and synaptic impairment in patient iPSC-derived cerebral organoids of CSF1R-related disorder.

Li Chi, Haitao Tu, Zhihong Li, Lifeng Qiu, Zhi-Wei Zhang, Sook-Yoong Chia, Jayne Yi Tan, Ivy A W Ho, Yuin-Han Loh, Eng-King Tan and 5 more

Abstract read
In one paragraph

Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Virtual single-cell perturbation and genetic causal inference revealJournal of cell communication and signaling · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Li Chi *Guangdong Provincial Key Laboratory of Stomatology, Hospital of Stomatology, Institute of Stomatological Research, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China.
Haitao Tu *Neural Stem Cell Research Lab, Research Department, National Neuroscience Institute, Singapore, Singapore.ORCID http://orcid.org/0000-0001-7499-0682
Zhihong LiNeural Stem Cell Research Lab, Research Department, National Neuroscience Institute, Singapore, Singapore.
Lifeng QiuNeural Stem Cell Research Lab, Research Department, National Neuroscience Institute, Singapore, Singapore.
Zhi-Wei ZhangNeural Stem Cell Research Lab, Research Department, National Neuroscience Institute, Singapore, Singapore.
Sook-Yoong ChiaNeural Stem Cell Research Lab, Research Department, National Neuroscience Institute, Singapore, Singapore.
Jayne Yi TanDepartment of Neurology, National Neuroscience Institute, Singapore, Singapore.
Ivy A W HoMolecular Neurotherapeutics Laboratory, National Neuroscience Institute, Singapore, Singapore.
Yuin-Han LohInstitute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), Singapore, Singapore.
Eng-King TanNeuroscience & Behavioral Disorders Program, DUKE-NUS Graduate Medical School, Singapore, Singapore.
Wei TengGuangdong Provincial Key Laboratory of Stomatology, Hospital of Stomatology, Institute of Stomatological Research, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, China.
Zhong PeiGuangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Department of Neurology, The First Affiliated Hospital; National Key Clinical Department and Key Discipline of Neurology, Sun Yat-Sen University, Guangzhou, China.
Zbigniew K WszolekDepartment of Neurology, Mayo Clinic Florida, Jacksonville, FL, USA.
Adeline S L NgNeuroscience & Behavioral Disorders Program, DUKE-NUS Graduate Medical School, Singapore, Singapore.
Li ZengNeural Stem Cell Research Lab, Research Department, National Neuroscience Institute, Singapore, Singapore. Li_Zeng@nni.com.sg.ORCID http://orcid.org/0000-0003-3242-2286

Funding

Guangzhou Science and Technology Program key projects 2024A04J4952MOH | National Medical Research Council (NMRC) LCG002-SPARK IIMOH | National Medical Research Council (NMRC) MOH-CIRG21nov-0001MOH | National Medical Research Council (NMRC) OFIRG23jul-0075
6 · The paper itself

Abstract

CSF1R-related disorder (CSF1R-RD) is a rare autosomal dominant neurodegenerative disease characterized by cognitive decline, motor dysfunction, psychiatric symptoms, and white matter abnormalities. It is caused by mutations in the CSF1R gene. Despite the identification of many pathogenic CSF1R variants, the molecular mechanisms behind neuropathogenesis in CSF1R-RD remain poorly understood due to the lack of disease modeling. This study focuses on a novel CSF1R mutation, T567M, located outside the tyrosine kinase domain, whose pathogenic impact has not been characterized. To gain molecular insights into the pathogenic mechanisms of the CSF1R-T567M mutation, we established an induced pluripotent stem cell (iPSC) model system consisting of mutant (CSF1R-MT) and CRISPR/Cas9-corrected isogenic control lines. Using these iPSCs, we generated iPSC-derived microglia (iMGL) and cerebral organoids (COs). Through RNA sequencing, we identified altered genes and pathways involved in neuroinflammation in MT iMGL. We then investigated microglial migration, phagocytosis, cytokine profiling, neurodevelopment, and synaptic function in iMGL and iMGL-CO co-culture to study the role of T567M mutation in CSF1R-RD. Our research revealed that the CSF1R-MT caused haploinsufficiency of CSF1R, reducing autophosphorylation of CSF1R at Tyr546 and activating autophagy. CSF1R-MT iMGL induced neuroinflammation, increased phagocytosis, and impaired migration. Transcriptomic analysis showed upregulation of immune activity and downregulation of synaptic function. Additionally, CSF1R-MT promoted proliferation, inhibited neural differentiation and maturation, and caused neurodevelopmental defects in COs. Whole-cell patch-clamp recordings indicated impaired synaptic function in CSF1R-MT COs. Furthermore, CSF1R-MT microglia impaired synaptic protein expression when co-cultured with CSF1R-MT COs. Collectively, our study provides detailed mechanistic insights into the pathogenesis driven by the CSF1R-T567M mutation, highlighting the critical role of CSF1R signaling in neural homeostasis. This isogenic iPSC model serves as a valuable platform for probing mutation-specific mechanisms and future therapeutic screening.

Identifiers

PMID41820324
PMCPMC13039969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.